Chemical Composition and the Anticancer, Antimicrobial, and Antioxidant Properties of <i>Acacia</i> Honey from the Hail Region: The in vitro and in silico Investigation

Hamadou, Walid Sabri; Bouali, Nouha; Badraoui, Riadh; Hadj Lajimi, Ramzi; Hamdi, Assia; Alreshidi, Mousa; Patel, Mitesh; Adnan, Mohd; Siddiqui, Arif Jamal; Noumi, Emira; Rao Pasupuleti, Visweswara; Snoussi, Mejdi

doi:https://doi.org/10.1155/2022/1518511

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments Supplementary Materials References Copyright Related Articles

Special Issue

Natural Products Potentiate the Anticancer Effect of Chemotherapeutics

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 1518511 | https://doi.org/10.1155/2022/1518511

Chemical Composition and the Anticancer, Antimicrobial, and Antioxidant Properties of Acacia Honey from the Hail Region: The in vitro and in silico Investigation

Walid Sabri Hamadou,¹Nouha Bouali,¹Riadh Badraoui,^1,2,3Ramzi Hadj Lajimi,^4,5Assia Hamdi,⁶Mousa Alreshidi,^1,7Mitesh Patel,⁸Mohd Adnan,¹Arif Jamal Siddiqui,¹Emira Noumi,^1,9Visweswara Rao Pasupuleti ,^10,11and Mejdi Snoussi^1,12

Academic Editor: Mohammed El-Magd

Received03 Apr 2022

Revised27 May 2022

Accepted28 Jun 2022

Published04 Aug 2022

Abstract

In consideration of the emergence of novel drug-resistant microbial strains and the increase in the incidences of various cancers throughout the world, honey could be utilized as a great alternative source of potent bioactive compounds. In this context, this study pioneers in reporting the phytochemical profiling and the antimicrobial, antioxidant, and anticancer properties of Acacia honey (AH) from the Hail region of Saudi Arabia, assessed using in vitro and molecular docking approaches. The phytochemical profiling based on high-resolution liquid chromatography-mass spectrometry (HR-LCMS) revealed eight compounds and three small peptide-like proteins as the constituents. The honey samples exhibited promising antioxidant activities (DPPH-IC₅₀ = 0.670 mg/mL; ABTS-IC₅₀ = 1.056 mg/mL; β-carotene-IC₅₀ > 5 mg/mL). In the well-diffusion assay, a high mean growth inhibition zone (mGIZ) was observed against Staphylococcus aureus (48.33 ± 1.53 mm), Escherichia coli ATCC 10536 (38.33 ± 1.53 mm), and Staphylococcus epidermidis ATCC 12228 (39.33 ± 1.15 mm). The microdilution assay revealed that low concentrations of AH could inhibit the growth of almost all the evaluated bacterial and fungal strains, with the minimal bactericidal concentration values (MBCs) ranging from 75 mg/mL to 300 mg/mL. On the contrary, high AH concentrations were required to kill the tested microorganisms, with the minimal bactericidal concentration values (MBCs) ranging from approximately 300 mg/mL to over 600 mg/mL and the minimal fungicidal concentration values (MFCs) of approximately 600 mg/mL. The AH exhibited effective anticancer activity in a dose-dependent manner against breast (MCF-7), colon (HCT-116), and lung (A549) cancer cell lines, with the corresponding IC₅₀ values of 5.053 μg/mL, 5.382 μg/mL, and 6.728 μg/mL, respectively. The in silico investigation revealed that the observed antimicrobial, antioxidant, and anticancer activities of the constituent compounds of AH are thermodynamically feasible, particularly those of the tripeptides (Asp-Trp-His and Trp-Arg-Ala) and aminocyclitol glycoside. The overall results highlighted the potential of AH as a source of bioactive compounds with significant antimicrobial, antioxidant, and anticancer activities, which could imply further pharmacological applications of AH.

1. Introduction

The emergence of novel drug-resistant microbial strains and the high prevalence of various cancers have heavily burdened the existing healthcare system. The main challenge is to discover novel therapeutic strategies. Complementary medicine using natural products or their derivative phytochemicals could serve as a great alternative for overcoming these healthcare-related concerns, and honey could be an interesting choice in this regard [1]. Honey and its products have been valorized for their high nutritional value and medicinal properties for a long time. Owing to its therapeutic value, honey is used as an essential ingredient in several formulations of folk medicine. The diversity of the specific phytochemical compositions of honey could provide valuable bioactive molecules to be used in the treatment of various cancers and infections with drug-resistant bacterial strains. Certain highly antioxidant and bioactive constituent molecules in honey have been reported to exhibit prominent therapeutic results against several forms of cancers. So far, over 200 constituent compounds have been reported in honey. This complexity of honey could explain its antimicrobial and anticancer activities and its capacity to modulate oxidative stress. The most common bioactive compounds reported in honey, which are considered responsible for its anticancer activity, are flavonoids and phenolic acids [2]. These compounds exhibit several mechanisms for anticancer activity, including apoptosis, inhibition of the tumor necrosis factor, and antiproliferative, immunomodulatory, and anti-inflammatory effects [2]. Honey samples derived from several regions have been investigated for their antioxidant, antimicrobial, and anticancer activities, with different results reported for different subtypes and various floral and geographical origins of honey [3]. The various kinds of honey derived from Saudi Arabia have been particularly highlighted for their interesting displays of biological activity [4–7]. In the Kingdom of Saudi Arabia, beekeeping constitutes an important economic activity, with several varieties of honey produced as this region has abundant natural flora most suitable for beekeeping. Talh or Acacia is the dominant bee plant in this region. This plant belongs to the subfamily Mimosoideae under the family Fabaceae, which comprises several species, including Acacia albida, Acacia asak, Acacia ehrenbergiana, Acacia etbaica, Acacia johnwoodii, Acacia oerfota, and Acacia tortilis [8].

Acacia honey (AH) is quite popular in Saudi Arabia owing to its nutritional value and medicinal properties. The composition and properties of AH mainly depend on the geographical and floral origin of the honey and also on the environmental factors, including seasons. Several studies have highlighted that the chemical composition of honey may even vary with climatic conditions and soil composition [9]. Recent studies revealed that honey samples obtained from different altitudes in the same region exhibited different phytochemical compositions, particularly the levels of total phenols and flavonoids, which could lead to different biological activities. The antioxidant, antimicrobial, and anticancer potentials of AH have been revealed in several studies. The reported results varied according to the bioactive phytochemical composition of AH, which mainly depends on the geographical origin of the honey sample [7]. Therefore, this study aimed at investigating, for the first time, the phytochemical composition of AH from the Hail region using the HR-LCMS technique to evaluate the antioxidant potential of the selected honey and estimate its anticancer activity against human lung, breast, and colon cancer cell lines. In addition, the antimicrobial potential of the selected AH against several bacterial strains, yeast, and molds was investigated using the well-diffusion and microdilution assays. The targeted biological activities were also assessed by studying the molecular interactions with the selected receptors using the molecular docking approach.

2. Materials and Methods

2.1. Honey Sampling

Talh (Acacia sp.) honey samples were collected directly from the beekeeper in the melliferous areas of the Hail region. The collected honey samples were stored at 4°C in glass jars in the dark until to be used for subsequent analyses.

2.2. Phytochemical Profiling of Acacia Honey

2.2.1. Identification of Bioactive Compounds Using the HR-LCMS Technique

In order to determine the phytochemistry of AH, chromatographic analysis was performed using the UHPLC-PDA-detector mass spectrophotometer (HR-LCMS 1290 INFINITY UHPLC System, Agilent Technologies, Santa Clara (CA, USA), as described previously by Adnan et al. [10]. A 10-μL aliquot from the honey sample was injected into the SBC18 column (2.1 mm × 50 mm; particle size 1.8 μm). The elution was performed using 1% formic acid in deionized water (solvent A) and acetonitrile (solvent B) at a flow rate of 0.350 mL/min. The MS detection was performed using MS Q-TOF in positive and negative atmospheric pressure chemical ionization modes. PubChem was employed as the main tool for the identification of the phytochemical constituents in the honey samples.

2.2.2. Determination of Total Phenols, Flavonoids, and Tannins

Total phenols, flavonoids, and tannins were quantified using the standard protocols described in previous reports [11, 12].

2.3. Antioxidant Activities

The antioxidant activities were evaluated using three tests DPPH, ABTS, and β-carotene bleaching tests. The test protocols used were obtained from previous reports [13, 14].

2.3.1. DPPH Radical-Scavenging Activity

The DPPH (2,2-diphenyl-1-picryl-hydrazyl-hydrate) (Sigma-Aldrich Milano, Italy) free radical-scavenging activities of the honey samples were determined using an antioxidant assay based on electron-transfer reaction. In this assay, DPPH is reduced in the presence of an antioxidant molecule. Several dilutions of the honey were incubated with DPPH for 30 min at room temperature. Ascorbic acid was used as the standard control. The variation in the color of DPPH was assessed based on spectrophotometric analysis at 515 nm. The antioxidant activity was expressed as IC₅₀ (mg/mL) and calculated using the following formula:where A₀ denotes the absorbance of the control and A₁ denotes the absorbance of the sample.

2.3.2. ABTS Radical-Scavenging Activity

The ABTS (2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid); Sigma-Aldrich Milano, Italy) radical-scavenging activity of the honey samples was assessed. In order to generate ABTS⁺, 7 mM ABTS was allowed to react with 2.45 mM K₂S₂O₈ for 12 h in the dark at room temperature. Several concentrations of the honey were mixed with 900 μL of the solution-containing ABTS⁺, and the mixture was incubated for 30 min. The antioxidant activity was expressed as IC₅₀ (mg/mL), representing the AH concertation scavenging 50% of ABTS⁺. The ABTS-scavenging activity was calculated using the following formula:where A₀ denotes the absorbance of the control and A₁ denotes the absorbance of the sample.

2.3.3. β-Carotene/Linoleic Acid Method

The β-carotene method was performed as described by Ikram et al. [15], and the inhibition of the volatile organic compounds and the conjugated diene hydroperoxides arising from linoleic acid oxidation was measured. In the reaction, the free radical linoleic acid attacked the highly unsaturated β-carotene in the presence of antioxidants (Acacia honey in this case). The prepared emulsion mixture was incubated at 50°C in the dark, followed by measuring the absorbance at 470 nm immediately (t = 0 min) and after 2 h of incubation (t = 120 min). Ascorbic acid was used as the standard for comparison. The antioxidant activity of honey was estimated using the following equation:

2.4. Antimicrobial Activity of the Obtained Crude Extract

2.4.1. Well-Diffusion Assay

One mL of the honey sample to be evaluated (1 mL = 1.0653 g) was diluted in 5% dimethyl sulfoxide (DMSO) to prepare solutions with the final concentration ranging from 532.65 mg/mL to 26 mg/mL. Subsequently, the well-diffusion assay was performed to determine the diameter of the growth inhibition zone on agar medium (Mueller–Hinton for bacteria, Sabouraud Chloramphenicol agar for yeasts, and potato dextrose agar for molds) using the protocols described by Noumi et al. [12, 16]. The evaluated strains were obtained from a huge microbial collection available in the microbiology laboratory of our college and included the following twelve bacteria: Pseudomonas aeruginosa (clinical strain, SP-40), Staphylococcus aureus ATCC 29213, S. epidermidis ATCC 12228, Escherichia coli ATCC 10536, Klebsiella pneumoniae (clinical strain, 140), E. coli (clinical strain, 217), S. aureus (clinical strain), S. sciuri (environmental strain), Serratia marcescens, Acinetobacter baumannii (clinical strain, 146), methicillin-resistant S. aureus (MRSA clinical strain, 136), and Enterobacter cloacae (clinical strain 155). The antifungal activity of the AH to be evaluated was investigated against the following five yeasts and two molds: Candida albicans ATCC 20402, Saccharomyces cerevisiae (instant yeast), C. vaginalis (clinical strain, 136), C. guilliermondii ATCC 6260, C. tropicalis ATCC 1362, Aspergillus fumigatus ATCC 204305, and A. Niger. The antibacterial activity was evaluated using the agar well-diffusion assay. Using a sterile borer (diameter 7 mm), four wells were created in the agar plate and filled with 100 μL of AH at different concentrations (100%, 75%, 50%, and 25%). The pure colonies of microorganisms that appeared on the appropriate agar media were selected to prepare homogenous (bacterial/fungal) suspensions. A cotton swab was used for inoculating fresh Petri dishes.

The treated Petri dishes were maintained at 4°C for 1 h and then incubated at 37°C for the next 24 h. The antimicrobial activity was evaluated by measuring the diameter of the growth inhibition zone around the wells. All tests were performed in triplicate, and the mean diameter of the inhibition zone was used as the final diameter value. The results obtained were interpreted using the scheme proposed by Parveen et al., which was as follows: no activity growth inhibition zone 0 (GIZ 0), low activity (GIZ: 1–6 mm), moderate activity (GIZ: 7–10 mm), high activity (GIZ: 11–15 mm), and extremely high activity (GIZ: 16–20 mm). Ampicillin (10 mg/mL; 10 μL/disc) and amphotericin B (10 mg/mL; 10 μL/disc) treatments were performed in the control experiments.

2.4.2. Microdilution Assay

The microdilution method was adopted to determine the MICs and MBCs (minimum bactericidal concentrations)/MFC values of the honey samples, as described previously [17]. First, a stock solution was prepared in 5% DMSO. Next, twofold serial dilutions of the honey samples were prepared in the wells of 96-well plates, beginning from 532.65 mg/mL to 26 mg/mL, using Mueller–Hinton broth for bacteria and Sabouraud Chloramphenicol broth for yeasts and molds. The microbial inoculum (5 μL) was then added to each well of the microtiter plate containing 0.1 mL of the serially diluted honey. This was followed by incubation at 37°C for 24 h. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of the compound that could inhibit microbial growth. In order to determine the MBC/MFC values, 3 μL of the medium was removed from the wells with no visible growth and inoculated on Mueller–Hinton/Sabouraud Chloramphenicol agar plates. After 24 h of incubation at 37°C, microbial growth was observed. The concentration at which the microorganisms were killed (no growth) was recorded as the minimum bactericidal/fungicidal concentration. The MBC/MIC and MFC/MIC ratios were used to determine the activity of the honey samples as described in previous reports [18, 19].

2.5. Anticancer Assay Using MTT Assay

The anticancer potential of AH was evaluated against three human cancer cell lines using the MTT (3-(4,5-dimethylthiazolyl-2)-2,5 diphenyl tetrazolium bromide) assay. The three cell lines used in this study, namely, the lung cancer (A549), breast cancer (MCF-7), and colon cancer (HCT-116) cell lines, were provided by the National Centre for Cell Science (NCCS), Pune, India. Doxorubicin (Sigma, India) was used as the reference drug in the MTT assay. The cells were maintained at 37°C, 5% CO₂, and 80% humidity in 25-cm² flasks containing Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 10,000 U/mL penicillin, and 5 mg/mL streptomycin (Hi-Media, India). When 80% confluence was reached, the cells were seeded in the wells of a 96-well plate at a density of 1 × 10⁵ cells per well, followed by incubation at the conditions stated above. The cells were stained with approximately 0.4% trypan blue stain (Hi-Media, India) to estimate the number of viable cells using a hemocytometer. All treatments were performed in triplicate, each for 24 h and with different concentrations of AH (2%, 4%, 6%, 8%, and 10%) prepared by diluting AH in complete media and sterilized using filtration (0.22 μm filter). After incubation, the plate was removed from the incubator, and the medium containing AH was aspirated and then washed with phosphate-buffered saline (PBS). Afterward, the cells were incubated with 100 μL of the MTT (Hi-Media, India) solution (5 mg/mL) for 4 h. Subsequently, 100 μL of DMSO was added for crystal solubilization, and the absorbance was recorded at the wavelengths of 570 nm and 630 nm using an ELISA reader. The percentage growth inhibition was calculated after subtracting the background and the blank, and the concentration of the evaluated drug required to inhibit cell growth by 50% (IC₅₀) was calculated from the dose-response curve for the respective cell line as described in a previous report [20].

2.6. The In Silico Analysis

The targeted biological activities were confirmed using the in silico molecular docking and interaction approach. The macromolecules identified in the composition of honey samples were obtained from RCSB. The macromolecules with the PDB IDs 1JIJ, 2XCT, 2QZW, and 1HD2 were subjected to the assessment of antibacterial, antifungal, and antioxidant activities. Similarly, 4UYA, 1JNX, and 4BBG were evaluated for their potential anticancer effect on colon, breast, and lung cancers, respectively. The chemical structures of all macromolecules were drawn using ChemDraw and saved in the. sdf format. The docking approach was based on the CHARMm force field after processing the receptors by adding polar hydrogens and Kollman charges and removing the crystal water molecules [21, 22] in AutoDock Vina and DS visualizer. The binding affinity and hydrogen bond assessment calculations were performed as described previously [21–24].

2.7. Statistical Analysis

All experiments and measurements were conducted in triplicate, and the results were presented as mean values ± SD (standard deviations). ANOVA, Duncan’s, and Bonferroni tests were performed using SPSS 16.0 and GraphPad Prism 5.0. The means of the result values obtained in the tests were also evaluated with the least significant differences test at .

3. Results

3.1. Phytochemical Profiling of Acacia Honey

High-resolution liquid chromatography-mass spectrometry (HR-LCMS) was performed to determine the chemical composition of AH. This technique enabled the separation and identification of the phytoconstituents based on their retention time, database difference (library), experimental m/z, MS/MS fragments, metabolite class, and the proposed compounds. The MS data were generated in both negative and positive ionization modes. The complete list is provided in Table 1. The technique identified small peptide-like proteins in AH (one dipeptide and two tripeptides), with the respective molecular weights ranging from 271.1674 g/mol to 456.1732 g/mol.

The negative and positive runs identified 9 compounds belonging to different chemical classes, including 6-(alpha-D-glucosaminyl)-1D-myo-inositol, L-gulonate, anabasamine, bakankoside, palmitic amide, stearamide, acetylenic acids, 10,16-heptadecadien-8-ynoic acid, 7-hydroxy, (E), and 14-fluoro-myristic acid. The chemical structures of the identified molecules are depicted in Figure 1.

3.2. Antimicrobial Activities of Acacia Honey

The mean diameters of the growth inhibition zones observed for the evaluated AH samples against 12 bacteria, 5 yeasts, and 2 molds are listed in Table 2. The highest mGIZ value for all the evaluated bacteria was obtained when honey was used at 100% concentration. At this concentration, S. aureus (clinical strain), E. coli (clinical strain 217), and S. epidermidis ATCC 12228 were revealed as the most sensitive strains, with the corresponding mGIZ values of approximately 40.67 ± 0.57 mm, 50.33 ± 0.57 mm, and 40.33 ± 0.57 mm, respectively (Figure 2).

(a)

(b)

(c)

The most resistant bacterial strains were A. baumannii (clinical strain, 146), which exhibited an mGIZ value of approximately 6.00 ± 0 mm. The evaluated AH could not better inhibit the growth of any of the selected yeasts and molds compared to the reference antifungal drug (amphotericin B), except for the growth of the S. cerevisiae strain, for which the mGIZ values ranged from 15.00 ± 0 mm at 75% of AH to 20.00 ± 0 mm when pure AH (100%) was used (Figure 2).

The findings of the microdilution method revealed that the lowest MIC values of 75 mg/mL were obtained against the staphylococcal species (S. aureus, S. epidermidis, and S. scuri) and S. marscescens. On the other hand, 300 mg/mL of AH was required to inhibit the growth of methicillin-resistant S. aureus strain. The MIC values of the fungal strains ranged from 150 mg/mL to 300 mg/mL. Higher concentrations of AH were required to completely kill the bacteria in all evaluated strains (the MBC values ranged from 300 mg/mL to 600 mg/mL). In addition, AH concentrations higher than 600 mg/mL were required to reproduce a fungicidal action against Candida and Saccharomyces strains. The results obtained using the scheme proposed by Gatsing et al. [19] revealed that AH exhibited bactericidal activity against most Gram-positive and Gram-negative bacteria, with the corresponding MBC/MIC ratios of ≤4. Similarly, the evaluated honey samples exhibited fungistatic activity against the selected yeast, with an MFC/MIC ratio of ≤4. All the above data are provided in Table 3.

3.3. Antioxidant Potential of Acacia Honey

The total phenolics, flavonoid, and tannin contents in the AH samples are listed in Table 4. Among the three different approaches used to assess the antioxidant activity of AH, the highest scavenging activity was observed using the DPPH assay, which revealed an IC₅₀ value of 0.670 mg/mL, followed by the ABTS and β-carotene assays, which revealed the IC₅₀ values of 1.065 mg/mL and >5 mg/mL, respectively.

3.4. Anticancer Activity of Acacia Honey

The results of the cytotoxicity evaluation of AH against breast cancer (MCF-7), lung cancer (A549), and colon cancer (HCT-116) cell lines are summarized in Figure 3. AH exhibited promising anticancer activity against the selected cancer cell lines, with the corresponding IC₅₀ values of 5.053 μg/mL, 5.382 μg/mL, and 6.728 μg/mL against the breast, colon, and lung cancer cell lines.

3.5. The in silico Analysis

In order to better understand the mechanistic effects underlying the biological effects of the compounds identified in AH, the binding affinities and molecular interactions of several receptors involved in these biological activities were assessed. The selection of the reported positions was based on the best binding score and RMSD equal to zero, as is commonly reported in the existing literature [22–24]. As presented in Table 5, while all the constituent compounds of AH exhibited negative binding energies (ranging from −3.8 to −11 kcal/mol) with the different targeted receptors, the best scores were obtained for the complex compound no. 1 and the JIJ receptor. The number of conventional hydrogen bonds, the number of the closest interacting residues, and the closest distance during the ligand-receptor complex formation are presented in Table 6. It was predicted that compound no. 5 established 12 conventional hydrogen bonds with the TyrRS for S. aureus tyro-syl-tRNA synthetase (1JIJ). This was the highest number of H-bonds revealed in this study. Interestingly, 12 closest interacting residues were also observed in the same complex (Figures 4and5), among which Asp195 was the closest (2.037 Å). Moreover, it was predicted that compound no. 6 established 11 conventional H-bonds with 1JNX and evolved 8 closest interacting residues. The distance to Arg1753 was just 2.020 Å, which confirmed that the compound was deeply embedded. Overall, the tripeptides (compound nos. 5 and 6) and aminocyclitol glycoside (compound no. 1) appeared to exhibit better activities toward the different targeted receptors compared to the other classes of compounds. This was particularly true for the tripeptides (Asp-Trp-His and Trp-Arg-Ala) (Figures 4 and 5) (see Figure 6).

(a)

(b)

4. Discussion

The present study reports eight dominant phytochemicals and three small peptide-like proteins identified in AH using the LC-MS technique. Several phytochemicals have been reported previously in AH [25–28]. The techniques such as liquid chromatography together with UV detection and liquid chromatography-electrochemical detection (LC-ECD) are often employed to determine the contents of phenolic acids in honey samples [26, 29–31]. In 2014, Wang and colleagues demonstrated that the AH collected from beekeepers in the region of Shaanxi (China) was rich in chlorogenic acid, p-hydroxybenzoic acid, ellagic acid, gallic acid, syringic acid, rosmarinic acid, and protocatechuic acid [26]. Kaempferol rhamnosides and rhamnosyl glucosides have been reported as the markers for AH [32, 33]. In the present study, a pyridine alkaloid compound named anabasamine was isolated, which has also been reported previously in the chemical composition analysis of Anabasis aphylla L. [34, 35]. Anabasamine is reported to possess weak anti-acetylcholinesterase and anti-inflammatory properties [36, 37]. Three small peptide-like proteins (two tripeptides and one dipeptide) were also identified in the present study. Previously, Al Aerjani and colleagues have also used the same technique (LC-MS) and reported identifying short and cyclic peptides in the A. hamulosa honey with high medicinal effects, including antioxidant, antimicrobial, and antitumor effects. These peptides were also reported as potential weight loss-inducing peptides [31]. The small peptide-like proteins identified in the honey samples in the present study were two tripeptides (Asp-Trp-His and Trp-Arg-Ala) and a dipeptide (Pro-Arg). Previous studies have demonstrated that peptides containing tyrosine, arginine, tryptophan, methionine, lysine, cysteine, and histidine residues exhibit higher antioxidant activities [38]. Recently, it was demonstrated that tripeptides (Asn-Asn-Asn, His-Phe-Gln, Gln-His-Phe, Thr-Leu-Trp, and Gln-Phe-Tyr) identified in the aqueous and methanolic extracts of Allium subhirsutum L. (bulbs) interacted with the structural and nonstructural proteins of SARS-CoV-2 with high binding energy [39].

Several studies have highlighted that honey exhibits antimicrobial potential, particularly against a wide spectrum of pathogenic bacteria, including both Gram-positive and Gram-negative bacteria [40–43]. The emergence of novel drug-resistance bacterial strains has instigated the search for novel phytochemicals with antimicrobial potential. The complexity of the chemical composition of honey and its intrinsic characteristics contribute to the valuable antimicrobial properties that honey exhibits [40]. Several mechanisms and target bacterial sites could be responsible for this antimicrobial property of honey, rendering honey resistance a rare event [41]. The honey that has been most commonly investigated for its antimicrobial potential is Manuka honey. The antimicrobial potential of this honey has mainly been associated with the high value of methylglyoxal (MGO) [42]. A comparative analysis of the antibacterial effects of Manuka honey and AH revealed a valuable result in favor of AH [43]. In addition, AH from various geographical regions has been demonstrated to exhibit interesting antimicrobial potentials in several studies [5]. The studies exploring the proprieties of honey samples from Saudi Arabia have revealed significant variation in their physicochemical characteristics, total phenolic contents, pigments, hydrogen peroxide levels, and dicarbonyl compounds with the botanical origin, climate, and altitudes, particularly for the AH samples from this region [7, 44, 45].

In the present study, the antibacterial activity of AH was observed to vary in a dose-dependent manner, with higher antibacterial activities achieved at 100% AH concentration. At this concentration, the efficiency of AH was higher, with the highest mGIZ value obtained against S. aureus (clinical strain), E. coli (clinical strain 217), and S. epidermidis ATCC 12228 (mGIZ values: 40.67 ± 0.57 mm, 50.33 ± 0.57 mm, and 40.33 ± 0.57 mm, respectively). These results were interesting when compared to the mGIZ values observed for ampicillin, which was used as a reference. A recent study on different kinds of honey from Saudi Arabia revealed that AH exhibited a more potent antibacterial effect against several microbial strains, with higher mGIZ values obtained against Gram-positive bacteria compared to when using other kinds of honey [46]. Moreover, B. cereus, S. aureus, E. coli, and Salmonella enteritidis were reported as the most sensitive bacterial species [5, 46]. These findings were consistent with the results of the present study, particularly those obtained for S. aureus and E. coli. The present study also revealed that the antimicrobial potential of AH was dose-dependent, with the highest activity observed when pure honey was used. In another study, the authors concluded that the antimicrobial activity increased when water-diluted honey (33% w/v) was used rather than nondiluted honey [46]. This could be due to the difference in the honey moisture rate. The most resistant bacteria were A. baumannii (clinical strain 146), with the mGIZ value of approximately 6.00 ± 0 mm. A recent study investigating the novel nano-composite hydrogels comprising silver nanoparticles (AgNPs) and AH revealed that these hydrogels exhibited strong bactericidal activity against standard nosocomial strains, while A. baumannii exhibited a notable resistance [47]. Therefore, it was inferred that A. baumannii could exhibit resistance against AH, although this must be confirmed through further investigation.

Furthermore, the activity of AH against the yeast and molds was almost negligible, except for a moderate activity exhibited against S. cerevisiae with an mGIZ value of 20 ± 0 mm, which was higher than the corresponding mGIZ value obtained for amphotericin (7.33 ± 0.57 mm). Mracevic et al. [48] evaluated 20 kinds of honey collected from different regions of Serbia, including AH, against C. albicans and reported that none exhibited any potency. Another study evaluated several honey samples, including AH, and reported resistance in 9 fungal strains (F. oxysporum, A. brasiliensis, A. alternate, D. stemonitis, T. longibrachiatum, T. harzianum, P. canescens, P. cyclopium, and C. albicans) [49]. These findings are consistent with the results obtained in the present study, indicating that most fungal strains could be resistant to honey. The mechanism of this resistance should, however, be deciphered through further investigation.

The microdilution assay performed for twelve bacteria revealed a significant bactericidal activity of AH against P. aeruginosa (clinical strain SP-40), E. coli ATCC 10536, E. coli (clinical strain 217), S. aureus (clinical strain), A. baumannii (clinical strain 146), and S. aureus MR (clinical strain 136) strains, with the obtained MBC/MIC ratio of 2. In the case of the yeast and fungi, fungistatic effects were observed mainly, with the MFC/MIC ratio of ≥4, which could be the reason for the fungal resistance to AH. Previous studies on the antimicrobial effects of the AH obtained from different regions against a wide variety of bacteria, yeast, and mold strains have reported that the corresponding MIC and MBC/MFC values vary with the chemical composition of the honey sample evaluated. Stojkovska and colleagues [47] reported that AH collected from Serbia in 2018 exhibited antimicrobial activity against a huge collection of Gram-positive and Gram-negative bacteria, and also against certain fungal strains. These authors reported MIC values ranging from 25 mg/mL for B. cereus ATCC 10876 strain to >100 mg/mL for E. coli ATCC 25922, P. aeruginosa ATCC 10145, S. typhimrium ATCC 14028, S. epidermidis ATCC 12228, K. pneumoniae ATCC 70063, B. subtilis ATCC 6633, E. faecalis ATCC 29212, and Micrococcus lysodeikticus ATCC 4698. The AH from Serbia also exhibited anti-C. albicans activity with an MFC value of >100 mg/mL [49]. Moreover, Yousaf and colleagues [50] reported that the AH collected from Malaysia exhibited activity against S. aureus, E. coli, S. typhimirium, P. aeruginosa, Listeria monocytogenes, Clostridium jejuni ATCC 29428, and B. cereus, with the MIC values ranging from 25% to 50%, while the MBC values ranged from 50% to >50%. A comparison of the results obtained in the present study with the findings of previous studies revealed that AH exhibits an efficient antimicrobial activity against most bacterial strains, particularly the Gram-positive bacteria [51, 52]. The variation in the antimicrobial effect of AH observed in several studies could be attributed mainly to the variations in the composition and constituent phytochemical compounds of AH, which are, in turn, influenced by the botanical origin and the physicochemical properties (osmotic effect, pH, and the presence of undefined molecules with antimicrobial effect) of the honey sample [52–54]. Therefore, AH could be a valuable alternative treatment option for the pathologies associated with drug-resistant bacterial strains. However, the incomplete knowledge regarding the constituent bioactive phytochemicals and their mechanisms of action creates another level of complexity in the use of AH for the treatment of infections. Such reasons have limited the application of honey in conventional medicine in the absence of standardization of antibacterial activity [55, 56].

Since honey is derived from plants, it contains several phytochemicals that confer antioxidant properties to honey. The antioxidant potential of honey is due to the presence of bioactive compounds, such as phenols, flavonoids, and tannins, which are capable of inactivating the free radicals generated during diverse cellular processes. Accumulation of free radicals could have a cytotoxic effect or maybe potentially carcinogenic. In the present study, the free radical-scavenging activity of AH was investigated using three approaches: DPPH radical-scavenging activity, ABTS radical-scavenging activity, and β-carotene/linoleic acid method. These three methods revealed IC₅₀ values of 0.670 mg/mL, 1.065 mg/mL, and >5 mg/mL, respectively, with the highest scavenging activity observed in the DPPH assay. These results were comparable to those obtained for butylated hydroxytoluene (BHT) and ascorbic acid (AA), which were used as references. Therefore, it was inferred that AH derived from the Hail region exhibited significant antioxidant potency. In addition, the total phenolics content (TPC, 6.546 mg GAE/g), total flavonoid contents (TFC, 0.400 mg QE/g), and tannin contents (5.352 mg TAE/g) obtained were interesting. According to a previous report, the AH from Ordu in Turkey exhibited an IC₅₀ value of 24.53 ± 1.26 mg/mL when using the DPPH approach, with the estimated total phenol content of 51.91 ± 1.32 mg/100 g GAE [57]. In another study, the AH from central Serbia exhibited an antioxidant potential with IC₅₀ = 8.36 ± 0.42 mg Trolox/kg honey, total phenolics content = 68.48 ± 5.53 mg GAE/kg honey, and flavonoid content = 18.59 ± 1.71 mg QUE/kg honey [49]. The AH from the Hail region used in the present study, comparatively, exhibited a higher antioxidant activity. On the contrary, the total phenolics content (TPC) and total flavonoid content (TFC) observed for Malaysian AH were relatively higher (79.08 mg GAE/1 mg and 20.98 mg CE/1 mg, respectively) compared to the AH used in the present study, indicating that the antioxidant properties of the former would enable inhibiting the growth of breast cancer cells through apoptosis [58]. However, even though the AH from the Hail region contained lower levels of TPC and TFC compared to Malaysian AH, higher anticancer activity was observed for this AH in the MTT assay. The TPC and TFC contents may vary with the geographical and botanical origins of the honey samples. A strong antioxidant capacity of AH may, therefore, not be related to the phenolics, flavonoid, or tannin contents only. The phytochemical profiling in the present study revealed the presence of various chemical compounds, such as polypeptides, in the AH, and the synergies among these compounds could also be involved in the mechanism underlying the antioxidant activity of this honey.

Several in vitro and in vivo studies have demonstrated the anticancer activity of various kinds of honey against different types of cancers. Raw honey contains high levels of polyphenols and flavonoids, which are considered the main factors contributing to antioxidant and anticancer effects. Studies have also demonstrated the efficiency of honey as a chemo-protectant or an adjuvant in cancer treatment [59]. In addition, certain phytochemicals derived from honey exert a therapeutic effect for the treatment of various types of cancer and are, therefore, to be considered prominent chemo-preventive agents [60]. There could be several mechanisms underlying the anticancer effect of honey, including cell cycle arrest, induction of apoptosis, modulation of the mitochondrial pathway, membrane permeabilization, and anti-inflammatory and immunomodulatory effects [2]. AH is considered a potential therapeutic candidate for both the prevention and treatment of cancer. This potential of AH, however, varies in the degree of effectiveness with the floral source of AH and/or the geographical regions from which the AH samples are derived [61].

In the present study, the anticancer potential of the AH from the Hail region of Saudi Arabia was evaluated based on the MTT assay using 3 cancer cell lines: breast cancer (MCF-7), lung cancer (A549), and colon cancer (HCT-116) cell lines. All three cell lines were treated with different concentrations of AH, and it was observed that the proliferation of cancer cell lines was inhibited in a dose-dependent manner. The IC₅₀ values obtained for AH against the breast, colon, and lung cancer cell lines were 5.053 μg/mL, 5.382 μg/mL, and 6.728 μg/mL, respectively. These results demonstrated a cytotoxic effect of the AH from the Hail region against cancer cells. In a previous investigation, doxorubicin was reported to exhibit an IC₅₀ value of 1.2 ± 0.036 μg/mL for the HCT-116 cell line and 1.09 ± 0.044 μg/mL for the MCF-7 cell line [7]. Another study investigating the AH from the Asir region (southwest of Saudi Arabia) reported a notable cytotoxic effect against HCT-116, MCF-7, and HepG2 cell lines. The authors also reported that the AH from different altitudes of this region exerted different degrees of in vitro effects on the cancer cell lines [7]. The high-altitude AH exhibited higher activity against human cancer cell lines compared to that exhibited by the low-altitude AH, and there was a noticeable difference in the total phenolics and flavonoid contents as well. In the present study, AH exhibited a higher anticancer activity against HCT-116 and MCF-7 cancer cell lines, which could be attributed to the differences in the composition of AH from the Hail region and that from the Asir region.

Previous studies have also highlighted that AH from Malaysia inhibits the growth of breast cancer cell line MCF-7 via apoptosis. The induction of apoptosis occurred after 2 h, while the formation of the apoptotic bodies could be detected within 6 h of the AH treatment [58]. The IC₅₀ value of AH from Malaysia was 5.49 μg/mL after 72 h, while that of the AH used in the present study was 5.053 μg/mL after just 24 h of treatment, indicating the higher cytotoxic activity of the latter.

Another study targeting the lung cell cancer line NCI-H460 revealed that AH could inhibit cancer cell proliferation and cause cell cycle arrest at G0/G1 phase. In addition, it was demonstrated that AH might induce the downregulation of bcl-2 and p53 genes [62]. This cytotoxic effect was also observed in the present study against the lung cancer cell line A549.

Recently, studies have revealed that generating silver (Ag) nanoparticles in the presence of AH (Abha, Saudi Arabia) and the plant extract of Calotropis procera produces exhibit a synergic effect with prominent anticancer potentials through the inhibition of the liver cancer cell line HepG2 growth with good immunostimulatory effect [63]. Earlier studies have reported that the anticancer potential of honey may vary with the subtype of honey, even when the same honey from different geographical regions is used. This variation is attributed to the variations in the constituents of the honey samples [64]. The anticancer properties of honey have been attributed mainly to the phytochemicals present in the honey, particularly the flavonoids and phenolic acids. These phytochemicals confer cancer prevention and treatment abilities by interfering in several cellular pathways [65]. In the present study, interesting anticancer activities were demonstrated by AH against three cancer cell lines. In addition to attributing this anticancer activity to the quantitative evaluation of flavonoids and phenolic acids, we should also consider other bioactive compounds that might be contributing to the qualitative constitution of honey. In the present study, tripeptides and aminocyclitol glycoside present in the AH from the Hail region were observed to contribute to enhancing the biological potency of honey.

Furthermore, the binding affinities and molecular interactions of the constituents of honey were assessed against several receptors involved in the studied biological activities (Figure S1). One of these receptors is 1JIJ, which is a S. aureus tyrosyl-tRNA synthetase and is commonly recognized to provide a structural basis for designing novel antimicrobial agents [66, 67]. Another one is 2 × ct, which is a type IIA topoisomerase that cleaves and then ligates DNA strands to regulate the DNA topology. Type IIA topoisomerases represent a major class of antibacterial and anticancer drug targets [68]. The receptor 2QZW is an aspartic proteinase Sap 1 secreted from Candida albicans, which reportedly plays a key role in superficial Candida infections [69]. The human peroxiredoxin 5, 1 hd2, reduces hydrogen-and alkyl hydroperoxides and is implicated in the antioxidant protective mechanisms and cellular signal transduction [70]. The MLK4 kinase domain 4uya regulates the JNK, p38, and ERK kinase signaling pathways. Mutations in MLK4 have been detected in several cancers [71]. The receptor 1JNX is the C-terminal BRCT region of BRCA1 and is essential for DNA repair, tumor suppressor functions, and transcriptional regulation [72]. The receptor 4bbg is the mitotic kinesin Eg5 and is critical for the assembly of the mitotic spindle and a promising chemotherapy target [73]. All the compounds present in honey exhibited negative binding energies (ranging from −3.8 to −11 kcal/mol) with the different targeted receptors. As reported in several studies, the variation in the binding affinity could mainly be attributed to the chemical structure of the compound [22, 74, 75]. Usually, there is a strong relationship between the structure and the activity of a compound, which explains the importance of SAR and QSAR analyses. In the present study, the best binding score was obtained for the 1JIJ-aminocyclitol glycoside complex. The tripeptide Asp-Trp-H is formed 12 conventional H bonds with the TyrRS in the S. aureus tyrosyl-tRNA synthetase (1JIJ). The closest molecular interactions included 12 residues in the active site. Aminocyclitol glycoside was deeply embedded in the active site of the different targeted receptors (1.864–2.617 Å) and was at a distance of only 2.037 Å from the Asp195 residue in 1JIJ, for which the highest binding affinity was reported. The closely related ligand-amino acids/protein complexes could explain the biological activity [21–24]. The compound 6 (Asp-Trp-His) was predicted to form 11 conventional H-bonds with 1JNX and evolve 8 closest interacting residues. It was at a distance of only 2.020 Å from Arg1753, which satisfactorily explained the potential biological activity. Furthermore, the molecular interactions of the different complexes usually included certain key residues associated with the pharmacological effects [67, 74, 75]. Overall, the biological effects of the phytochemical compounds in honey appeared to be thermodynamically feasible, particularly those of the tripeptides and aminocyclitol glycoside. These computational results in parallel with the findings of in vitro analysis could explain the promising effects of AH and its ethnopharmaceutical use worldwide, particularly in the Middle East region. Owing to the complexity of the composition of AH, there is incomplete knowledge regarding its constituent phytochemicals and their mechanisms of action, which is the main reason for the limited application of honey in conventional medicine in the absence of standardization of biological activities. Therefore, further studies are required to isolate and characterize each compound for a better understanding of the involved mechanism of action.

5. Conclusions

The present study reports the potential biological activities of the AH from the Hail region of Saudi Arabia. A broad-range bactericidal effect of AH against a wide spectrum of clinically relevant bacterial strains was observed. On the other hand, only fungistatic activity was observed for the yeast and the molds. A notable cytotoxic effect of AH was observed on the three cancer cell lines evaluated. Among the identified phytochemicals, the tripeptides and aminocyclitol glycoside exhibited considerable biological effects of enhancing the antimicrobial, anticancer, and antioxidant potentials of AH. In addition, huge amounts of polyphenols and flavonoids were detected in the evaluated honey samples. Nonetheless, further studies on the isolation, characterization, and assessment of these biological activities of the compounds in AH in the present study should be conducted to support the above-stated findings. The findings of the present study demonstrate the potential of AH as a source of natural bioactive compounds that could be used for therapeutic purposes.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

This research has been funded by Scientific Research Deanship at the University of Hail, Hail, Saudi Arabia through project number RG-21 109.

Supplementary Materials

Figure S1: The 2D diagrams of the closest interactions exhibited by AH major identified compounds complexed with the different targeted receptors displaying the most significant molecular interactions. (Supplementary Materials)

References

F. El-Gamal, A. Bajubair, A. Hejji, A. Jarwan, and J. N. Salah, “Complementary and alternative medicine practice and perceptions of Saudi subjects in western region of Saudi Arabia,” Middle East Journal of Family Medicine, vol. 7, no. 10, p. 88, 2022.
View at: Google Scholar
M. Waheed, M. B. Hussain, A. Javed et al., “Honey and cancer: a mechanistic review,” Clinical Nutrition, vol. 38, no. 6, pp. 2499–2503, 2019.
View at: Publisher Site | Google Scholar
G. Cebrero, O. Sanhueza, M. Pezoa et al., “Relationship among the minor constituents, antibacterial activity and geographical origin of honey: a multifactor perspective,” Food Chemistry, vol. 315, Article ID 126296, 2020.
View at: Publisher Site | Google Scholar
I. A. Alotibi, S. M. Harakeh, M. Al-Mamary et al., “Floral markers and biological activity of Saudi honey,” Saudi Journal of Biological Sciences, vol. 25, no. 7, pp. 1369–1374, 2018.
View at: Publisher Site | Google Scholar
A. G. Hegazi, F. M. Al Guthami, A. F. M. Al Gethami, A. A. Saleh, and E. A. Fouad, “Potential antibacterial activity of some Saudi Arabia honey,” Veterinary World, vol. 10, no. 2, pp. 233–237, 2017.
View at: Publisher Site | Google Scholar
H. A. Ghramh, K. A. Khan, and A. M. A. Alshehri, “Antibacterial potential of some Saudi honeys from Asir region against selected pathogenic bacteria,” Saudi Journal of Biological Sciences, vol. 26, no. 6, pp. 1278–1284, 2019.
View at: Publisher Site | Google Scholar
M. E. A. Mohammed, A. A. Shati, M. Y. Alfaifi et al., “Acacia honey from different altitudes: total phenols and flavonoids, laser-induced fluorescence (LIF) spectra, and anticancer activity,” Journal of International Medical Research, vol. 48, no. 8, Article ID 030006052094345, 2020.
View at: Publisher Site | Google Scholar
A. A. Al-Ghamdi, Comprehensive Study for Current Beekeeping Industry of Imported and Native Honeybee in Kingdom of Saudi Arabia, Final Report King Abdulaziz City for Science and Technology General Administration of Grant Program King Saud University, Riyadh, Saudi Arabia, 2010.
L. A. Marghitas, D. S. Dezmirean, C. B. Pocol, I. L. E. A. Marioara, O. Bobis, and I. Gergen, “The development of a biochemical profile of Acacia honey by identifying biochemical determinants of its quality,” Notulae Botanicae Horti Agrobotanici Cluj-Napoca, vol. 38, no. 2, pp. 84–90, 2010.
View at: Publisher Site | Google Scholar
M. Adnan, A. J. Siddiqui, W. S. Hamadou et al., “Phytochemistry, bioactivities, pharmacokinetics and toxicity prediction of Selaginella repanda with its anticancer potential against human lung, breast and colorectal carcinoma cell lines,” Molecules, vol. 26, no. 3, p. 768, 2021.
View at: Publisher Site | Google Scholar
F. Haddaji, A. Papetti, E. Noumi et al., “Bioactivities and in silico study of Pergularia tomentosa L. phytochemicals as potent antimicrobial agents targeting type IIA topoisomerase, TyrRS, and Sap1 virulence proteins,” Environmental Science and Pollution Research, vol. 28, no. 20, pp. 25349–25367, 2021.
View at: Publisher Site | Google Scholar
E. Noumi, M. Snoussi, E. H. Anouar et al., “HR-LCMS-based metabolite profiling, antioxidant, and anticancer properties of Teucrium polium L. methanolic extract: computational and in vitro study,” Antioxidants, vol. 9, no. 11, p. 1089, 2020.
View at: Publisher Site | Google Scholar
K. Mseddi, F. Alimi, E. Noumi et al., “Thymus musilii Velen. as a promising source of potent bioactive compounds with its pharmacological properties: in vitro and in silico analysis,” Arabian Journal of Chemistry, vol. 13, no. 8, pp. 6782–6801, 2020.
View at: Publisher Site | Google Scholar
K. Aouadi, H. Hajlaoui, S. Arraouadi, S. Ghannay, M. Snoussi, and A. Kadri, “HPLC/MS phytochemical profiling with antioxidant activities of Echium humile desf. extracts: ADMET prediction and computational study targeting human peroxiredoxin 5 receptor,” Agronomy, vol. 11, no. 11, p. 2165, 2021.
View at: Publisher Site | Google Scholar
E. H. K. Ikram, K. H. Eng, A. M. M. Jalil et al., “Antioxidant capacity and total phenolic content of Malaysian underutilized fruits,” Journal of Food Composition and Analysis, vol. 22, no. 5, pp. 388–393, 2009.
View at: Publisher Site | Google Scholar
M. Alreshidi, E. Noumi, L. Bouslama et al., “Phytochemical screening, antibacterial, antifungal, antiviral, cytotoxic, and anti-quorum-sensing properties of Teucrium polium L. aerial parts methanolic extract,” Plants, vol. 9, no. 11, p. 1418, 2020.
View at: Publisher Site | Google Scholar
H. Hajlaoui, M. Snoussi, E. Noumi, S. Zanetti, R. Ksouri, and A. Bakhrouf, “Chemical composition, antioxidant and antibacterial activities of the essential oils of five Tunisian aromatic plants,” Italian Journal of Food Science, vol. 22, pp. 320–329, 2010.
View at: Google Scholar
D. Gatsing, J. A. Mbah, and I. H. Garba, “An antisalmonellal agent from the leaves of Glossocalyx brevipes benth (Monimiaceae),” Pakistan Journal of Biological Sciences, vol. 9, no. 1, 2006.
View at: Publisher Site | Google Scholar
D. Gatsing, V. Tchakoute, D. Ngamga et al., “In vitro antibacterial activity of Crinum purpurascens herb leaf extract against the salmonella species causing typhoid fever and its toxicological evaluation,” Iranian Journal of Medical Sciences, vol. 34, no. 2, 2009.
View at: Google Scholar
M. Adnan, A. J. Siddiqui, W. S. Hamadou et al., “Deciphering the molecular mechanism responsible for efficiently inhibiting metastasis of human non-small cell lung and colorectal cancer cells targeting the matrix metalloproteinases by Selaginella repanda,” Plants, vol. 10, no. 5, p. 979, 2021.
View at: Publisher Site | Google Scholar
A. Akacha, R. Badraoui, T. Rebai, and L. Zourgui, “Effect of Opuntia ficus indica extract on methotrexate-induced testicular injury: a biochemical, docking and histological study,” Journal of Biomolecular Structure and Dynamics, vol. 40, no. 10, pp. 4341–4351, 2020.
View at: Publisher Site | Google Scholar
R. Badraoui, M. Adnan, F. Bardakci, and M. M. Alreshidi, “Chloroquine and hydroxychloroquine interact differently with ACE2 domains reported to bind with the coronavirus spike protein: mediation by ACE2 polymorphism,” Molecules, vol. 26, no. 3, p. 673, 2021.
View at: Publisher Site | Google Scholar
K. Hchicha, M. Korb, R. Badraoui, and H. Naïli, “A novel sulfate-bridged binuclear copper (II) complex: structure, optical, ADMET and in vivo approach in a murine model of bone metastasis,” New Journal of Chemistry, vol. 45, no. 31, Article ID 13784, 2021.
View at: Publisher Site | Google Scholar
N. Zammel, M. Saeed, N. Bouali et al., “Antioxidant and anti-inflammatory effects of Zingiber officinale roscoe and Allium subhirsutum: in silico, biochemical and histological study,” Foods, vol. 10, no. 6, p. 1383, 2021.
View at: Publisher Site | Google Scholar
M. Biesaga and K. Pyrzyńska, “Stability of bioactive polyphenols from honey during different extraction methods,” Food Chemistry, vol. 136, no. 1, pp. 46–54, 2013.
View at: Publisher Site | Google Scholar
J. Wang, X. Xue, X. Du et al., “Identification of Acacia honey adulteration with rape honey using liquid chromatography-electrochemical detection and chemometrics,” Food Analytical Methods, vol. 7, no. 10, pp. 2003–2012, 2014.
View at: Publisher Site | Google Scholar
N. Czipa, C. J. C. Phillips, and B. Kovács, “Composition of Acacia honeys following processing, storage and adulteration,” Journal of Food Science & Technology, vol. 56, no. 3, pp. 1245–1255, 2019.
View at: Publisher Site | Google Scholar
N. M. Mădaş, L. A. Mărghitaş, D. S. Dezmirean et al., “Volatile profile and physico-chemical analysis of Acacia honey for geographical origin and nutritional value determination,” Foods, vol. 8, no. 10, p. 445, 2019.
View at: Publisher Site | Google Scholar
Y. Liang, W. Cao, W. J. Chen, X. H. Xiao, and J. B. Zheng, “Simultaneous determination of four phenolic components in Citrus honey by high performance liquid chromatography using electrochemical detection,” Food Chemistry, vol. 114, no. 4, pp. 1537–1541, 2009.
View at: Publisher Site | Google Scholar
T. Istasse, N. Jacquet, T. Berchem, E. Haubruge, B. K. Nguyen, and A. Richel, “Extraction of honey polyphenols: method development and evidence of cis isomerization ubertas academica,” Analytical Chemistry Insights, vol. 11, Article ID ACI.S39739, 2016.
View at: Publisher Site | Google Scholar
W. M. A. Al Aerjani, S. A. Abu-Melha, K. A. Khan et al., “Presence of short and cyclic peptides in Acacia and Ziziphus honeys may potentiate their medicinal values,” Open Chemistry, vol. 19, no. 1, pp. 1162–1173, 2021.
View at: Publisher Site | Google Scholar
I. Martos, M. Cossentini, F. Ferreres, and F. A. Tomás-Barberán, “Flavonoid composition of Tunisian honeys and propolis,” Journal of Agricultural and Food Chemistry, vol. 45, no. 8, pp. 2824–2829, 1997.
View at: Publisher Site | Google Scholar
O. Escuredo, L. R. Silva, P. Valentão, M. C. Seijo, and P. B. Andrade, “Assessing Rubus honey value: pollen and phenolic compounds content and antibacterial capacity,” Food Chemistry, vol. 130, no. 3, pp. 671–678, 2012.
View at: Publisher Site | Google Scholar
S. Z. Mukhamedzhanov, K. A. Aslanov, A. S. Sadykov, V. B. Leont’ev, and V. K. Kiryukhin, “Structure of anabasamine,” Chemistry of Natural Compounds, vol. 4, no. 3, pp. 136–138, 1968.
View at: Publisher Site | Google Scholar
S. X. Lin, M. A. Curtis, and J. Sperry, “Pyridine alkaloids with activity in the central nervous system,” Bioorganic & Medicinal Chemistry, vol. 28, no. 24, Article ID 115820, 2020.
View at: Publisher Site | Google Scholar
A. Panthong, D. Kanjanapothi, Y. Thitiponpunt, T. Taesotikul, and D. Arbain, “Anti-inflammatory activity of the alkaloid anabasamine,” Doklady Akademii Nauk UzSSR, vol. 198, pp. 45–47, 1984.
View at: Google Scholar
Z. Tilyabaev and A. A. Abduvakhabov, “Alkaloids of Anabasis aphylla and their cholinergic activities,” Chemistry of Natural Compounds, vol. 34, no. 3, pp. 295–297, 1998.
View at: Publisher Site | Google Scholar
H. Guo, Y. Kouzuma, and M. Yonekura, “Structures and properties of antioxidative peptides derived from royal jelly protein,” Food Chemistry, vol. 113, no. 1, pp. 238–245, 2009.
View at: Publisher Site | Google Scholar
M. Snoussi, E. Noumi, A. Mosbah et al., “Tripeptides from Allium subhirsitum L. extracts: pharmacokinetics properties, toxicity prediction and in silico study against SARS-CoV-2 enzymes and pro-inflammatory proteins,” Cellular and Molecular Biology, vol. 67, no. 4, pp. 143–162, 2022.
View at: Publisher Site | Google Scholar
S. B. Almasaudi, A. A. Al-Nahari, E. S. M. Abd El-Ghany et al., “Antimicrobial effect of different types of honey on Staphylococcus aureus,” Saudi Journal of Biological Sciences, vol. 24, no. 6, pp. 1255–1261, 2017.
View at: Publisher Site | Google Scholar
P. Combarros-Fuertes, J. M. Fresno, M. M. Estevinho, M. Sousa-Pimenta, M. E. Tornadijo, and L. M. Estevinho, “Honey: another alternative in the fight against antibiotic-resistant bacteria?” Antibiotics, vol. 9, no. 11, p. 774, 2020.
View at: Publisher Site | Google Scholar
J. A. Lane, J. Calonne, H. Slattery, and R. M. Hickey, “Oligosaccharides isolated from MGO™ manuka honey inhibit the adhesion of Pseudomonas aeruginosa, Escherichia coli O157:H7 and Staphylococcus aureus to human HT-29 cells,” Foods, vol. 8, no. 10, 2019.
View at: Publisher Site | Google Scholar
K. Vesna, G. Bojan, and I. Tanja, “Agrores 2020,” in Proceedings of the International Symposium on Agricultural Sciences, Banja Luka, Bosnia and Herzegovina, 2020.
View at: Google Scholar
M. E. A. Mohammed, W. Alargani, M. A. Suleiman, and H. A. Al-Gramah, “Hydrogen peroxide and dicarbonyl compounds concentration in honey samples from different botanical origins and altitudes in the south of Saudi Arabia,” Current Research in Nutrition and Food Science Journal, vol. 7, no. 1, pp. 150–160, 2019.
View at: Publisher Site | Google Scholar
A. S. Alqarni, A. A. Owayss, and A. A. Mahmoud, “Physicochemical characteristics, total phenols and pigments of national and international honeys in Saudi Arabia,” Arabian Journal of Chemistry, vol. 9, no. 1, pp. 114–120, 2016.
View at: Publisher Site | Google Scholar
A. A. Owayss, K. Elbanna, J. Iqbal et al., “In vitro antimicrobial activities of Saudi honeys originating from Ziziphus spina-christi L. and Acacia gerrardii Benth. trees,” Food science & nutrition, vol. 8, no. 1, pp. 390–401, 2019.
View at: Publisher Site | Google Scholar
J. Stojkovska, P. Petrovic, I. Jancic, M. T. Milenkovic, and B. Obradovic, “Novel nano-composite hydrogels with honey effective against multi-resistant clinical strains of Acinetobacter baumannii and Pseudomonas aeruginosa,” Applied Microbiology and Biotechnology, vol. 103, no. 20, pp. 8529–8543, 2019.
View at: Publisher Site | Google Scholar
S. D. Mračević, M. Krstic, A. Lolic, and S. Razic, “Comparative study of the chemical composition and biological potential of honey from different regions of Serbia,” Microchemical Journal, vol. 152, Article ID 104420, 2020.
View at: Publisher Site | Google Scholar
N. Z. Srećković, V. B. Mihailović, and J. S. Katanić-Stanković, “Physico-chemical, antioxidant and antimicrobial properties of three different types of honey from central Serbia,” Kragujevac Journal of Science, vol. 41, pp. 53–68, 2019.
View at: Publisher Site | Google Scholar
K. Yousof, N. K. Mar, N. H. Za, and M. R. I. Fitry, “Antibacterial properties of tualang, acacia and yemeni sumur honey against selected food spoilage bacteria and foodborne pathogens,” Food Research, vol. 5, no. 1, pp. 448–460, 2021.
View at: Publisher Site | Google Scholar
N. A. Albaridi, “Antibacterial potency of honey,” International Journal of Microbiology, vol. 2019, Article ID 2464507, 10 pages, 2019, ‏.
View at: Publisher Site | Google Scholar
J. M. Alvarez-Suarez, S. Tulipani, D. Díaz et al., “Antioxidant and antimicrobial capacity of several monofloral cuban honeys and their correlation with color, polyphenol content and other chemical compounds,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2490–2499, 2010.
View at: Publisher Site | Google Scholar
P. Combarros-Fuertes, L. M. Estevinho, L. G. Dias et al., “Bioactive components and antioxidant and antibacterial activities of different varieties of honey: a screening prior to clinical application,” Journal of Agricultural and Food Chemistry, vol. 67, no. 2, pp. 688–698, 2019.
View at: Publisher Site | Google Scholar
A. Jeddar, A. Kharsany, U. G. Ramsaroop, A. Bhamjee, I. E. Haffejee, and A. Moosa, “The antibacterial action of honey. An in vitro study,” South African Medical Journal, vol. 67, no. 7, pp. 257-258, 1985.
View at: Google Scholar
P. H. S. Kwakman, A. A. Te Velde, L. de Boer, C. M. J. E. Vandenbroucke-Grauls, and S. A. J. Zaat, “Two major medicinal honeys have different mechanisms of bactericidal activity,” PLoS One, vol. 6, no. 3, Article ID e17709, 2011.
View at: Publisher Site | Google Scholar
R. Jenkins, A. Roberts, and H. L. Brown, “On the antibacterial effects of manuka honey: mechanistic insights,” Research and Reports in Biology, vol. 6, pp. 215–224, 2015.
View at: Publisher Site | Google Scholar
A. Gül and T. Pehlivan, “Antioxidant activities of some monofloral honey types produced across Turkey,” Saudi Journal of Biological Sciences, vol. 25, no. 6, pp. 1056–1065, 2018.
View at: Publisher Site | Google Scholar
M. A. Mohd Salleh, Z. Eshak, and W. I. Wan Ismail, “Acacia honey induces apoptosis in human breast adenocarcinoma cell lines (MCF-7),” Jurnal Teknologi, vol. 79, no. 4, 2017.
View at: Publisher Site | Google Scholar
A. P. Sponghini, D. Rondonotti, F. Platini et al., “A Simon’s two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities,” Journal of traditional and complementary medicine, vol. 11, no. 5, pp. 466–469, 2021.
View at: Publisher Site | Google Scholar
M. Badolato, G. Carullo, E. Cione, F. Aiello, and M. C. Caroleo, “From the hive: honey, a novel weapon against cancer,” European Journal of Medicinal Chemistry, vol. 142, pp. 290–299, 2017.
View at: Publisher Site | Google Scholar
A. Muhammad, O. A. Odunola, M. A. Ibrahim et al., “Potential biological activity of acacia honey,” Frontiers in Bioscience, vol. 8, no. 2, pp. 771–357, 2016.
View at: Publisher Site | Google Scholar
M. Aliyu, O. A. Odunola, A. D. Farooq et al., “Molecular mechanism of antiproliferation potential of Acacia honey on NCI-H460 cell line,” Nutrition and Cancer, vol. 65, no. 2, pp. 296–304, 2013.
View at: Publisher Site | Google Scholar
H. A. Ghramh, E. H. Ibrahim, and Z. Ahmad, “Antimicrobial, immunomodulatory and cytotoxic activities of green synthesized nanoparticles from Acacia honey and Calotropis procera,” Saudi Journal of Biological Sciences, vol. 28, no. 6, pp. 3367–3373, 2021.
View at: Publisher Site | Google Scholar
R. Farooq, S. Majid, A. Hanif, A. Ashraf, and A. Khan, “Different types of honey and their properties,” Therapeutic Applications of Honey and its Phytochemicals, Springer, New York, NY, USA, 2020.
View at: Publisher Site | Google Scholar
A. Rouamba, M. Compaoré, and M. Kiendrebeogo, “Molecular targets of honey bee’s products in cancer prevention and treatment,” Journal of Herbmed Pharmacology, vol. 8, no. 4, pp. 261–268, 2019.
View at: Publisher Site | Google Scholar
X. Qiu, C. A. Janson, W. W. Smith et al., “Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors,” Protein Science, vol. 10, pp. 2008–2016, 2001.
View at: Publisher Site | Google Scholar
I. M. M. Othman, M. A. M. Gad-Elkareem, H. A. Radwan et al., “Synthesis, structure-activity relationship and in silico studies of novel pyrazolothiazole and thiazolopyridine derivatives as prospective antimicrobial and anticancer agents,” ChemistrySelect, vol. 6, no. 31, pp. 7860–7872, 2021.
View at: Publisher Site | Google Scholar
B. D. Bax, P. F. Chan, D. S. Eggleston et al., “Type IIa topoisomerase inhibition by a new class of antibacterial agents,” Nature, vol. 466, no. 7309, pp. 935–940, 2010.
View at: Publisher Site | Google Scholar
C. Borelli, E. Ruge, J. H. Lee et al., “X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans,” Proteins, vol. 72, no. 4, pp. 1308–1319, 2008.
View at: Publisher Site | Google Scholar
J. P. Declercq, C. Evrard, A. Clippe, D. V. Stricht, A. Bernard, and B. Knoops, “Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 a resolution,” Journal of Molecular Biology, vol. 311, no. 4, pp. 751–759, 2001.
View at: Publisher Site | Google Scholar
A. A. Marusiak, N. L. Stephenson, H. Baik et al., “Recurrent Mlk4 loss-of-function mutations suppress jnk signaling to promote colon tumorigenesis,” Cancer Research, vol. 76, no. 3, pp. 724–735, 2016.
View at: Publisher Site | Google Scholar
R. S. Williams, R. Green, and J. N. Glover, “Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1,” Nature Structural Biology, vol. 8, no. 10, pp. 838–842, 2001.
View at: Publisher Site | Google Scholar
J. A. D. Good, F. Wang, O. Rath et al., “Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models,” Journal of Medicinal Chemistry, vol. 56, no. 5, pp. 1878–1893, 2013.
View at: Publisher Site | Google Scholar
R. Badraoui, M. Saeed, N. Bouali et al., “Expression profiling of selected immune genes and trabecular microarchitecture in breast cancer skeletal metastases model: effect of α-tocopherol acetate supplementation,” Calcified Tissue International, vol. 110, no. 4, pp. 475–488, 2022.
View at: Publisher Site | Google Scholar
R. Badraoui, M. Saoudi, W. S. Hamadou et al., “Antiviral effects of artemisinin and its derivatives against SARS-CoV-2 main protease: computational evidences and interactions with ACE2 allelic variants,” Pharmaceuticals, vol. 15, no. 2, p. 129, 2022.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Walid Sabri Hamadou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1090

Downloads

688

Citations